English
简体中文
Total: £ 56.28
Published Date: 2024-04-07 | Pages: 144 | Tables: 252 | Pharma & Healthcare
Porcine viral diarrhea is a common and frequently-occurring disease in pigs, and the most serious pathogens are porcine transmissible gastroenteritis virus (TGEV), porcine epidemic diarrhea virus (PEDV) and porcine rotavirus (PoRV). All three pathogens can infect pigs of all ages and can cause symptoms such as vomiting, watery diarrhea and dehydration. The harm to piglets within 10 days of age is particularly serious, and the morbidity and mortality are high, up to 100%. The vaccine is inoculated at the Houhai point, and it is safe and effective for all pigs including suckling piglets and pregnant sows. It realizes the prevention of three diseases with one shot, reduces the immune stress of pigs, and reduces the labor intensity and breeding of vaccination. cost, and has a significant effect on the prevention of single infection or mixed infection of the three pathogens.
The global market for Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine include Zoetis Animal Health, Boehringer-Ingelheim, Merck Animal Health, Ceva Santé Animale, MSD Animal Health, SPAH, Nanjing Tianbang Biological Technology, Sichuan Huapai Bio-pharmaceutical and Guangdong Winsun Bio Pharmaceutical, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine by region & country, by Type, and by Application.
The Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine.
Market Segmentation
By Company
Zoetis Animal Health
Boehringer-Ingelheim
Merck Animal Health
Ceva Santé Animale
MSD Animal Health
SPAH
Nanjing Tianbang Biological Technology
Sichuan Huapai Bio-pharmaceutical
Guangdong Winsun Bio Pharmaceutical
Wuhan Keqian Biology
Shanghai Hile Bio-Technology
Harbin Pharmaceutical Group Bio-Vaccine
Ringpu
Shandong Huahong Bioengineering
Weike Biotechnology
Nanjing Tianbang Biological Technology
China Animal Husbandry Industry
Segment by Type:
Live Vaccine
Inactivated Vaccine
Segment by Application
Piglets
Adults Pigs
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Introduction
1.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Size Forecast
1.2.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value (2019-2030)
1.2.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Volume (2019-2030)
1.2.3 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Price (2019-2030)
1.3 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Trends & Drivers
1.3.1 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Industry Trends
1.3.2 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Drivers & Opportunity
1.3.3 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Challenges
1.3.4 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Players Revenue Ranking (2023)
2.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Company (2019-2024)
2.3 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Players Sales Volume Ranking (2023)
2.4 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Volume by Company Players (2019-2024)
2.5 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price by Company (2019-2024)
2.6 Key Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine
2.9 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Competitive Analysis
2.9.1 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Live Vaccine
3.1.2 Inactivated Vaccine
3.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Type
3.2.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value, by Type (2019-2030)
3.2.3 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value, by Type (%) (2019-2030)
3.3 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Volume by Type
3.3.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Volume, by Type (2019-2030)
3.3.3 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Volume, by Type (%) (2019-2030)
3.4 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Piglets
4.1.2 Adults Pigs
4.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Application
4.2.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value, by Application (2019-2030)
4.2.3 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value, by Application (%) (2019-2030)
4.3 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Volume by Application
4.3.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Volume, by Application (2019-2030)
4.3.3 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Volume, by Application (%) (2019-2030)
4.4 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Region
5.1.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Region (2019-2024)
5.1.3 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Region (2025-2030)
5.1.4 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Region (%), (2019-2030)
5.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Volume by Region
5.2.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Volume by Region (2019-2024)
5.2.3 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Volume by Region (2025-2030)
5.2.4 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Volume by Region (%), (2019-2030)
5.3 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value, 2019-2030
5.4.2 North America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value, 2019-2030
5.5.2 Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value, 2019-2030
5.6.2 Asia Pacific Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value, 2019-2030
5.7.2 South America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value, 2019-2030
5.8.2 Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value
6.2.1 Key Countries/Regions Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value, 2019-2030
6.2.2 Key Countries/Regions Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value, 2019-2030
6.3.2 United States Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value, 2019-2030
6.4.2 Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value, 2019-2030
6.5.2 China Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Type (%), 2023 VS 2030
6.5.3 China Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value, 2019-2030
6.6.2 Japan Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value, 2019-2030
6.7.2 South Korea Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value, 2019-2030
6.8.2 Southeast Asia Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value, 2019-2030
6.9.2 India Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Type (%), 2023 VS 2030
6.9.3 India Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Zoetis Animal Health
7.1.1 Zoetis Animal Health Company Information
7.1.2 Zoetis Animal Health Introduction and Business Overview
7.1.3 Zoetis Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Zoetis Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Offerings
7.1.5 Zoetis Animal Health Recent Development
7.2 Boehringer-Ingelheim
7.2.1 Boehringer-Ingelheim Company Information
7.2.2 Boehringer-Ingelheim Introduction and Business Overview
7.2.3 Boehringer-Ingelheim Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Boehringer-Ingelheim Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Offerings
7.2.5 Boehringer-Ingelheim Recent Development
7.3 Merck Animal Health
7.3.1 Merck Animal Health Company Information
7.3.2 Merck Animal Health Introduction and Business Overview
7.3.3 Merck Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Merck Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Offerings
7.3.5 Merck Animal Health Recent Development
7.4 Ceva Santé Animale
7.4.1 Ceva Santé Animale Company Information
7.4.2 Ceva Santé Animale Introduction and Business Overview
7.4.3 Ceva Santé Animale Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Ceva Santé Animale Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Offerings
7.4.5 Ceva Santé Animale Recent Development
7.5 MSD Animal Health
7.5.1 MSD Animal Health Company Information
7.5.2 MSD Animal Health Introduction and Business Overview
7.5.3 MSD Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.5.4 MSD Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Offerings
7.5.5 MSD Animal Health Recent Development
7.6 SPAH
7.6.1 SPAH Company Information
7.6.2 SPAH Introduction and Business Overview
7.6.3 SPAH Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.6.4 SPAH Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Offerings
7.6.5 SPAH Recent Development
7.7 Nanjing Tianbang Biological Technology
7.7.1 Nanjing Tianbang Biological Technology Company Information
7.7.2 Nanjing Tianbang Biological Technology Introduction and Business Overview
7.7.3 Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Offerings
7.7.5 Nanjing Tianbang Biological Technology Recent Development
7.8 Sichuan Huapai Bio-pharmaceutical
7.8.1 Sichuan Huapai Bio-pharmaceutical Company Information
7.8.2 Sichuan Huapai Bio-pharmaceutical Introduction and Business Overview
7.8.3 Sichuan Huapai Bio-pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Sichuan Huapai Bio-pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Offerings
7.8.5 Sichuan Huapai Bio-pharmaceutical Recent Development
7.9 Guangdong Winsun Bio Pharmaceutical
7.9.1 Guangdong Winsun Bio Pharmaceutical Company Information
7.9.2 Guangdong Winsun Bio Pharmaceutical Introduction and Business Overview
7.9.3 Guangdong Winsun Bio Pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Guangdong Winsun Bio Pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Offerings
7.9.5 Guangdong Winsun Bio Pharmaceutical Recent Development
7.10 Wuhan Keqian Biology
7.10.1 Wuhan Keqian Biology Company Information
7.10.2 Wuhan Keqian Biology Introduction and Business Overview
7.10.3 Wuhan Keqian Biology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Wuhan Keqian Biology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Offerings
7.10.5 Wuhan Keqian Biology Recent Development
7.11 Shanghai Hile Bio-Technology
7.11.1 Shanghai Hile Bio-Technology Company Information
7.11.2 Shanghai Hile Bio-Technology Introduction and Business Overview
7.11.3 Shanghai Hile Bio-Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Shanghai Hile Bio-Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Offerings
7.11.5 Shanghai Hile Bio-Technology Recent Development
7.12 Harbin Pharmaceutical Group Bio-Vaccine
7.12.1 Harbin Pharmaceutical Group Bio-Vaccine Company Information
7.12.2 Harbin Pharmaceutical Group Bio-Vaccine Introduction and Business Overview
7.12.3 Harbin Pharmaceutical Group Bio-Vaccine Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Harbin Pharmaceutical Group Bio-Vaccine Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Offerings
7.12.5 Harbin Pharmaceutical Group Bio-Vaccine Recent Development
7.13 Ringpu
7.13.1 Ringpu Company Information
7.13.2 Ringpu Introduction and Business Overview
7.13.3 Ringpu Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Ringpu Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Offerings
7.13.5 Ringpu Recent Development
7.14 Shandong Huahong Bioengineering
7.14.1 Shandong Huahong Bioengineering Company Information
7.14.2 Shandong Huahong Bioengineering Introduction and Business Overview
7.14.3 Shandong Huahong Bioengineering Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Shandong Huahong Bioengineering Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Offerings
7.14.5 Shandong Huahong Bioengineering Recent Development
7.15 Weike Biotechnology
7.15.1 Weike Biotechnology Company Information
7.15.2 Weike Biotechnology Introduction and Business Overview
7.15.3 Weike Biotechnology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Weike Biotechnology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Offerings
7.15.5 Weike Biotechnology Recent Development
7.16 Nanjing Tianbang Biological Technology
7.16.1 Nanjing Tianbang Biological Technology Company Information
7.16.2 Nanjing Tianbang Biological Technology Introduction and Business Overview
7.16.3 Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Offerings
7.16.5 Nanjing Tianbang Biological Technology Recent Development
7.17 China Animal Husbandry Industry
7.17.1 China Animal Husbandry Industry Company Information
7.17.2 China Animal Husbandry Industry Introduction and Business Overview
7.17.3 China Animal Husbandry Industry Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.17.4 China Animal Husbandry Industry Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Offerings
7.17.5 China Animal Husbandry Industry Recent Development
8 Industry Chain Analysis
8.1 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Industrial Chain
8.2 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Model
8.5.2 Sales Channel
8.5.3 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Trends
Table 2. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Drivers & Opportunity
Table 3. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Challenges
Table 4. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Restraints
Table 5. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue Market Share by Company (2019-2024)
Table 7. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Volume by Company (2019-2024) & (K Doses)
Table 8. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Price by Company (2019-2024) & (US$/Dose)
Table 10. Key Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine
Table 13. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Doses)
Table 22. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Volume by Type (2019-2024) & (K Doses)
Table 23. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Volume by Type (2025-2030) & (K Doses)
Table 24. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Price by Type (2019-2024) & (US$/Dose)
Table 27. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Price by Type (2025-2030) & (US$/Dose)
Table 28. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Doses)
Table 34. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Volume by Application (2019-2024) & (K Doses)
Table 35. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Volume by Application (2025-2030) & (K Doses)
Table 36. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Price by Application (2019-2024) & (US$/Dose)
Table 39. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Price by Application (2025-2030) & (US$/Dose)
Table 40. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Region (2019-2024) & (%)
Table 44. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Region (2025-2030) & (%)
Table 45. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Volume by Region (K Doses): 2019 VS 2023 VS 2030
Table 46. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Volume by Region (2019-2024) & (K Doses)
Table 47. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Volume by Region (2025-2030) & (K Doses)
Table 48. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Volume by Region (2019-2024) & (%)
Table 49. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Volume by Region (2025-2030) & (%)
Table 50. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price by Region (2019-2024) & (US$/Dose)
Table 51. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price by Region (2025-2030) & (US$/Dose)
Table 52. Key Countries/Regions Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Volume, (2019-2024) & (K Doses)
Table 56. Key Countries/Regions Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Volume, (2025-2030) & (K Doses)
Table 57. Zoetis Animal Health Company Information
Table 58. Zoetis Animal Health Introduction and Business Overview
Table 59. Zoetis Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 60. Zoetis Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Offerings
Table 61. Zoetis Animal Health Recent Development
Table 62. Boehringer-Ingelheim Company Information
Table 63. Boehringer-Ingelheim Introduction and Business Overview
Table 64. Boehringer-Ingelheim Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 65. Boehringer-Ingelheim Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Offerings
Table 66. Boehringer-Ingelheim Recent Development
Table 67. Merck Animal Health Company Information
Table 68. Merck Animal Health Introduction and Business Overview
Table 69. Merck Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 70. Merck Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Offerings
Table 71. Merck Animal Health Recent Development
Table 72. Ceva Santé Animale Company Information
Table 73. Ceva Santé Animale Introduction and Business Overview
Table 74. Ceva Santé Animale Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 75. Ceva Santé Animale Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Offerings
Table 76. Ceva Santé Animale Recent Development
Table 77. MSD Animal Health Company Information
Table 78. MSD Animal Health Introduction and Business Overview
Table 79. MSD Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 80. MSD Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Offerings
Table 81. MSD Animal Health Recent Development
Table 82. SPAH Company Information
Table 83. SPAH Introduction and Business Overview
Table 84. SPAH Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 85. SPAH Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Offerings
Table 86. SPAH Recent Development
Table 87. Nanjing Tianbang Biological Technology Company Information
Table 88. Nanjing Tianbang Biological Technology Introduction and Business Overview
Table 89. Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 90. Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Offerings
Table 91. Nanjing Tianbang Biological Technology Recent Development
Table 92. Sichuan Huapai Bio-pharmaceutical Company Information
Table 93. Sichuan Huapai Bio-pharmaceutical Introduction and Business Overview
Table 94. Sichuan Huapai Bio-pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 95. Sichuan Huapai Bio-pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Offerings
Table 96. Sichuan Huapai Bio-pharmaceutical Recent Development
Table 97. Guangdong Winsun Bio Pharmaceutical Company Information
Table 98. Guangdong Winsun Bio Pharmaceutical Introduction and Business Overview
Table 99. Guangdong Winsun Bio Pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 100. Guangdong Winsun Bio Pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Offerings
Table 101. Guangdong Winsun Bio Pharmaceutical Recent Development
Table 102. Wuhan Keqian Biology Company Information
Table 103. Wuhan Keqian Biology Introduction and Business Overview
Table 104. Wuhan Keqian Biology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 105. Wuhan Keqian Biology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Offerings
Table 106. Wuhan Keqian Biology Recent Development
Table 107. Shanghai Hile Bio-Technology Company Information
Table 108. Shanghai Hile Bio-Technology Introduction and Business Overview
Table 109. Shanghai Hile Bio-Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 110. Shanghai Hile Bio-Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Offerings
Table 111. Shanghai Hile Bio-Technology Recent Development
Table 112. Harbin Pharmaceutical Group Bio-Vaccine Company Information
Table 113. Harbin Pharmaceutical Group Bio-Vaccine Introduction and Business Overview
Table 114. Harbin Pharmaceutical Group Bio-Vaccine Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 115. Harbin Pharmaceutical Group Bio-Vaccine Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Offerings
Table 116. Harbin Pharmaceutical Group Bio-Vaccine Recent Development
Table 117. Ringpu Company Information
Table 118. Ringpu Introduction and Business Overview
Table 119. Ringpu Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 120. Ringpu Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Offerings
Table 121. Ringpu Recent Development
Table 122. Shandong Huahong Bioengineering Company Information
Table 123. Shandong Huahong Bioengineering Introduction and Business Overview
Table 124. Shandong Huahong Bioengineering Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 125. Shandong Huahong Bioengineering Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Offerings
Table 126. Shandong Huahong Bioengineering Recent Development
Table 127. Weike Biotechnology Company Information
Table 128. Weike Biotechnology Introduction and Business Overview
Table 129. Weike Biotechnology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 130. Weike Biotechnology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Offerings
Table 131. Weike Biotechnology Recent Development
Table 132. Nanjing Tianbang Biological Technology Company Information
Table 133. Nanjing Tianbang Biological Technology Introduction and Business Overview
Table 134. Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 135. Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Offerings
Table 136. Nanjing Tianbang Biological Technology Recent Development
Table 137. China Animal Husbandry Industry Company Information
Table 138. China Animal Husbandry Industry Introduction and Business Overview
Table 139. China Animal Husbandry Industry Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 140. China Animal Husbandry Industry Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Offerings
Table 141. China Animal Husbandry Industry Recent Development
Table 142. Key Raw Materials Lists
Table 143. Raw Materials Key Suppliers Lists
Table 144. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Downstream Customers
Table 145. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Distributors List
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product Picture
Figure 2. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Volume (2019-2030) & (K Doses)
Figure 5. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Price (2019-2030) & (US$/Dose)
Figure 6. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Report Years Considered
Figure 7. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Players Sales Volume Ranking (2023) & (K Doses)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue in 2023
Figure 10. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Live Vaccine Picture
Figure 12. Inactivated Vaccine Picture
Figure 13. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Doses)
Figure 16. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Price by Type (2019-2030) & (US$/Dose)
Figure 18. Product Picture of Piglets
Figure 19. Product Picture of Adults Pigs
Figure 20. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value Market Share by Application, 2023 & 2030
Figure 22. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Doses)
Figure 23. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Volume Market Share by Application, 2023 & 2030
Figure 24. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Price by Application (2019-2030) & (US$/Dose)
Figure 25. North America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 26. North America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 27. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 28. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 29. Asia Pacific Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 30. Asia Pacific Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 31. South America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 32. South America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 33. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 34. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 35. Key Countries/Regions Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value (%), (2019-2030)
Figure 36. Key Countries/Regions Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Volume (%), (2019-2030)
Figure 37. United States Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 38. United States Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 39. United States Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 40. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 41. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 42. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 43. China Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 44. China Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 45. China Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 46. Japan Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 47. Japan Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 48. Japan Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 49. South Korea Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 50. South Korea Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 51. South Korea Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 52. Southeast Asia Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 53. Southeast Asia Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 54. Southeast Asia Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 55. India Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 56. India Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 57. India Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 58. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Industrial Chain
Figure 59. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturing Cost Structure
Figure 60. Channels of Distribution (Direct Sales, and Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
